Emerson Collective
VC Fund
Palo Alto, United States
Emerson Collective is a VC fund in Palo Alto focused on Software and Health Care. Emerson Collective operates as an investment and philanthropic organization that partners with entrepreneurs and innovators working on social and environmental challenges. The organization focuses on areas such as education, economic mobility, immigration, and the environment, combining investment, advocacy, and grantmaking approaches. Emerson Collective collaborates with individuals and organizations to develop and scale solutions aimed at expanding opportunity and addressing complex societal issues. Its activities include backing ventures, supporting nonprofit initiatives, and engaging in policy and community efforts.
- Total investments:
- 175
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries Emerson Collective invests in
Stages Emerson Collective invests in
Countries Emerson Collective invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 22 contacts → | |||
Round size
- Seed
- $1.5M–$14M
- Series A
- $7.5M–$100M
- Series B
- $15M–$150M
Investment Focus
Industry
- Software 27 (15%)
- Health Care 24 (14%)
- Biotechnology 21 (12%)
- Education 17 (10%)
- EdTech 13 (7%)
Stage
- Series A 34 (19%)
- Series B 29 (17%)
- Seed 26 (15%)
- Series C 23 (13%)
- Series D 19 (11%)
Country
- United States 111 (63%)
- Canada 2 (1%)
- France 2 (1%)
- United Kingdom 2 (1%)
- Iceland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Arne Duncan
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
Marc Ecko
Chair of Culture Council
|
Chair of Culture Council | Total investments: 3 | Find email | |
Sarah A. Pinto Peyronel
Partner (Senior Director)
|
Partner (Senior Director) | Total investments: 3 | Find email | |
Steve McDermid
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Amy Low
Managing Director, Communications
|
Managing Director, Communications | Total investments: 0 | Find email | |
| See all 22 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Collective X is a Women's Health Intelligence platform designed to bridge the historical research and data gap in women's health. It provides evidence-backed, female-specific insights built around female physiology to power the smart health ecosystem, ensuring that digital health products and clinical workflows don't rely on biased data. | $3.2M / Pre-Seed / Oct 13, 2026 | ||
| Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes. | $555M / Series G / Oct 01, 2026 | ||
| Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes. | $622M / Secondary Market / Oct 01, 2026 | ||
| InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies. | $77M / Series B / Aug 12, 2026 | ||
| GridCARE provides energy security and resilience at a never-before-seen pace, making it the indispensable one-stop power solution for AI data centers. | $64M / Series A / May 14, 2026 | ||
| The aim of Ultralight is to empower healthcare professionals to take charge of the future and make today's lives more lively. | $9.3M / Seed / Apr 13, 2026 | ||
| Stipple Bio is a biotech company that focuses on advancing cellular profiling and target discovery using epitope-level resolution technologies. It develops proprietary platforms that analyze cellular interactions, enabling researchers to identify precise therapeutic targets for drug development. The company’s approach is particularly applied inoncology, where it aims to discover tumor-specific cell surface epitopes to create safer and more effective treatments. Its “Pointillist” platform is designed to map these epitopes with high precision, helping overcome limitations of traditional therapies such as off-target toxicity. | $100M / Series A / Apr 06, 2026 | ||
World Labs
|
World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities. | $1B / Venture - Series Unknown / Feb 18, 2026 | |
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $100M / Series D / Feb 03, 2026 | ||
| Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiplesequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | $130M / Series B / Dec 15, 2025 | ||
| See all 175 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Emerson Collective invest in?
Emerson Collective invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 175 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Emerson Collective invest in?
Emerson Collective typically joins rounds of $1.5M–$14M at Seed, $7.5M–$100M at Series A and $15M–$150M at Series B. These are whole funding-round sizes, not Emerson Collective's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Emerson Collective took part in.
How do I contact Emerson Collective?
Public channels for Emerson Collective include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Emerson Collective?
The team at Emerson Collective includes Arne Duncan (Managing Partner), Marc Ecko (Chair of Culture Council) and Sarah A. Pinto Peyronel (Partner (Senior Director)), among 22 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
